Man Luo

657 total citations
20 papers, 541 citations indexed

About

Man Luo is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Man Luo has authored 20 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Man Luo's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (3 papers) and Inflammasome and immune disorders (3 papers). Man Luo is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (3 papers) and Inflammasome and immune disorders (3 papers). Man Luo collaborates with scholars based in China. Man Luo's co-authors include Qingsong Sun, Dongsheng Yan, Hongmei Zhao, Jiali Tao, Hong Sun, Liang Xu, Weidong Liu, Min Meng, Xiang Han and Yun Qiu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Cellular Physiology and Journal of Cellular Biochemistry.

In The Last Decade

Man Luo

19 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Man Luo China 13 322 156 100 65 60 20 541
Qingsong Sun China 11 246 0.8× 101 0.6× 81 0.8× 57 0.9× 87 1.4× 16 457
Xuexue Zhu China 14 315 1.0× 80 0.5× 102 1.0× 76 1.2× 107 1.8× 39 667
Peiwei Wang China 16 479 1.5× 202 1.3× 88 0.9× 96 1.5× 34 0.6× 37 751
Min Dai China 16 419 1.3× 146 0.9× 176 1.8× 40 0.6× 124 2.1× 26 771
Yanbin Gao China 16 446 1.4× 206 1.3× 48 0.5× 77 1.2× 94 1.6× 29 788
Jin Wen China 14 317 1.0× 151 1.0× 69 0.7× 29 0.4× 54 0.9× 32 641
Li Yan China 14 314 1.0× 77 0.5× 86 0.9× 71 1.1× 65 1.1× 31 641
Defeng Pan China 12 249 0.8× 75 0.5× 72 0.7× 124 1.9× 52 0.9× 40 558
Diem Thi Ngoc Huynh South Korea 14 315 1.0× 120 0.8× 80 0.8× 107 1.6× 65 1.1× 20 610
Jidong Cheng Japan 14 280 0.9× 93 0.6× 57 0.6× 45 0.7× 128 2.1× 31 702

Countries citing papers authored by Man Luo

Since Specialization
Citations

This map shows the geographic impact of Man Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Luo more than expected).

Fields of papers citing papers by Man Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Man Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Luo. The network helps show where Man Luo may publish in the future.

Co-authorship network of co-authors of Man Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Man Luo. A scholar is included among the top collaborators of Man Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Man Luo. Man Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, You, Wenjia Li, Man Luo, et al.. (2025). NUDT16 enhances the resistance of cancer cells to DNA-damaging agents by regulating replication fork stability via reversing HMGA1 ADP-ribosylation. Journal of Biological Chemistry. 301(6). 108551–108551.
2.
3.
Luo, Man, et al.. (2022). Alamandine alleviates hypertension and renal damage via oxidative-stress attenuation in Dahl rats. Cell Death Discovery. 8(1). 22–22. 15 indexed citations
4.
Sun, Qingsong, Man Luo, Zhiwei Gao, et al.. (2021). TUG1 knockdown suppresses cardiac fibrosis after myocardial infarction. Mammalian Genome. 32(6). 435–442. 15 indexed citations
5.
Sun, Qingsong, Man Luo, Zhiwei Gao, et al.. (2021). Long non-coding RNA OIP5-AS1 aggravates acute lung injury by promoting inflammation and cell apoptosis via regulating the miR-26a-5p/TLR4 axis. BMC Pulmonary Medicine. 21(1). 236–236. 11 indexed citations
6.
Luo, Man, Wei Sun, Bin Zhou, & Xiangqing Kong. (2021). Emodin alleviates aortic valvular calcification by inhibiting the AKT/FOXO1 pathway. Annals of Anatomy - Anatomischer Anzeiger. 240. 151885–151885. 5 indexed citations
7.
Tao, Jiali, Man Luo, Hong Sun, et al.. (2020). Overexpression of tripartite motif containing 26 inhibits non‐small cell lung cancer cell growth by suppressing PI3K/AKT signaling. The Kaohsiung Journal of Medical Sciences. 36(6). 417–422. 22 indexed citations
8.
Tao, Jiali, Hongmei Zhao, Xiaochen Xie, et al.. (2019). The anthelmintic drug flubendazole induces cell apoptosis and inhibits NF-κB signaling in esophageal squamous cell carcinoma. OncoTargets and Therapy. Volume 12. 471–478. 18 indexed citations
9.
Luo, Man, Dongsheng Yan, Qingsong Sun, et al.. (2019). Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and inflammation via the TLR4/NF‐kB/NLRP3 pathway. Journal of Cellular Biochemistry. 121(4). 2994–3004. 164 indexed citations
10.
11.
Yan, Dongsheng, et al.. (2019). LINC00261 suppresses human colon cancer progression via sponging miR‐324‐3p and inactivating the Wnt/β‐catenin pathway. Journal of Cellular Physiology. 234(12). 22648–22656. 42 indexed citations
12.
Luo, Man, Qingsong Sun, Hongmei Zhao, Jiali Tao, & Dongsheng Yan. (2019). Long noncoding RNA NEAT1 sponges miR‐495‐3p to enhance myocardial ischemia‐reperfusion injury via MAPK6 activation. Journal of Cellular Physiology. 235(1). 105–113. 30 indexed citations
13.
Gu, Yang, Man Luo, Yong Li, et al.. (2018). Bcl6 knockdown aggravates hypoxia injury in cardiomyocytes via the P38 pathway. Cell Biology International. 43(2). 108–116. 17 indexed citations
14.
Qiu, Yun, Yi‐Chen Wu, Min Meng, et al.. (2018). GYY4137 protects against myocardial ischemia/reperfusion injury via activation of the PHLPP-1/Akt/Nrf2 signaling pathway in diabetic mice. Journal of Surgical Research. 225. 29–39. 38 indexed citations
15.
Qiu, Yun, Min Meng, Man Luo, et al.. (2017). Rosuvastatin improves myocardial and neurological outcomes after asphyxial cardiac arrest and cardiopulmonary resuscitation in rats. Biomedicine & Pharmacotherapy. 87. 503–508. 12 indexed citations
16.
Luo, Man, Dandan Li, Yanying Wang, et al.. (2017). MD-2 regulates LPS-induced NLRP3 inflammasome activation and IL-1beta secretion by a MyD88/NF-κB-dependent pathway in alveolar macrophages cell line. Molecular Immunology. 90. 1–10. 51 indexed citations
17.
Gao, Zhiwei, Yingzi Huang, Hongmei Zhao, et al.. (2017). Impact of Intra-Aortic Balloon Counterpulsation on Prognosis of Patients with Acute Myocardial Infarction: A Meta-Analysis.. PubMed. 33(6). 567–577. 5 indexed citations
18.
Ren, Zhihong, Zun‐Ping Ke, Man Luo, & Yan Shi. (2017). Icariin protects against ischemia‑reperfusion injury in H9C2 cells by upregulating heat shock protein 20. Molecular Medicine Reports. 17(2). 3336–3343. 10 indexed citations
19.
Shi, Yan, Sijin Yang, Man Luo, Weidong Zhang, & Zun‐Ping Ke. (2017). Systematic analysis of coronary artery disease datasets revealed the potential biomarker and treatment target. Oncotarget. 8(33). 54583–54591. 14 indexed citations
20.
Li, Minghui, Yong Cai, Hongmei Zhao, et al.. (2015). Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients. Tumor Biology. 36(6). 4785–4792. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingsong Sun Breakdown of academic impact, for papers by Xuexue Zhu Breakdown of academic impact, for papers by Peiwei Wang Breakdown of academic impact, for papers by Min Dai Breakdown of academic impact, for papers by Yanbin Gao Breakdown of academic impact, for papers by Jin Wen Breakdown of academic impact, for papers by Li Yan Breakdown of academic impact, for papers by Defeng Pan Breakdown of academic impact, for papers by Diem Thi Ngoc Huynh Breakdown of academic impact, for papers by Jidong Cheng
Rankless by CCL
2026